- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01971307
Supporting Primary Care in Diagnosis and Choice of Treatment for Patients With Psychosocial Symptoms: SGEPsyScan. (SGE-PsyScan)
Although effective treatments for psychosocial symptoms and disorders are available, patients frequently do not receive the most appropriate and effective treatment for their symptoms because of inappropriate and unstructured diagnostics of psychosocial symptoms in general practice. The hypothesis is that by using the intervention SGE-PsyScan the clinical symptoms of patients can be assessed more uniformly and earlier as opposed to the GPs' assessment in usual care. As a result, patients are supposed to start earlier with a treatment that fits the type and severity of their symptoms better.
The patients will be randomly assigned to either receive the SGE-PsyScan or usual care.
Study Overview
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Eindhoven, Netherlands, 5605 LS
- Stichting Gezondheidscentra Eindhoven
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients with (suspected) psychosocial symptoms
- Aged 18 years or older and capacitated
- Adequate understanding of Dutch language
- Able to perform SGE-PsyScan at home, individually
Exclusion Criteria:
- Clear and treatable somatic causes of symptoms
- Acute distress/danger
- No written informed consent
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: SGE-PsyScan
The SGE-PsyScan is an internet application to which the General Practitioner (GP) refers the patient, which includes the distress screener, the 4-Dimensional Symptom Questionnaire (4DSQ) and a series of additional questions for differentiating between stress, depressive, anxious and somatization symptoms.
Based on the 4DSQ patients and GPs receive advices for possible treatments.
|
|
No Intervention: Usual care
Usual care for persons with psychosocial symptoms and disorders in Dutch primary care includes all usual care procedures; preventive, screening, diagnostic, (non-)pharmacological or therapeutic procedures which are routinely used in everyday care.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
The rate of patients who achieve a successful decrease in the level of psychosocial symptoms as measured with the Symptom Checklist 90 (SCL-90) after 12 months. A successful treatment result is defined as a decrease in the SCL-90 patient score of 50%.
Time Frame: 12 months
|
12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The level of psychosocial symptoms of patients as measured with the SCL-90
Time Frame: 3 months
|
3 months
|
|
The level of psychosocial symptoms of patients as measured with the SCL-90
Time Frame: 6 months
|
6 months
|
|
Health technology assessment
Time Frame: 3 months
|
We will measure direct and indirect costs in both groups with the Trimbos/iMTA questionnaire for Costs associated with Psychiatric Illness (TiC-P) and Electronic Medical Records (EMR) parameters indicating relevant expenditures including treatments, consultations and referrals
|
3 months
|
Health technology assessment
Time Frame: 6 months
|
We will measure direct and indirect costs in both groups with the Trimbos/iMTA questionnaire for Costs associated with Psychiatric Illness (TiC-P) and Electronic Medical Records (EMR) parameters indicating relevant expenditures including treatments, consultations and referrals
|
6 months
|
Health technology assessment
Time Frame: 9 months
|
We will measure direct and indirect costs in both groups with the Trimbos/iMTA questionnaire for Costs associated with Psychiatric Illness (TiC-P) and Electronic Medical Records (EMR) parameters indicating relevant expenditures including treatments, consultations and referrals
|
9 months
|
Health technology assessment
Time Frame: 12 months
|
We will measure direct and indirect costs in both groups with the Trimbos/iMTA questionnaire for Costs associated with Psychiatric Illness (TiC-P) and Electronic Medical Records (EMR) parameters indicating relevant expenditures including treatments, consultations and referrals
|
12 months
|
Quality of life will be measured using the EuroQol-5Dimensions-5Levels (EQ-5D-5L) questionnaire
Time Frame: 3 months
|
3 months
|
|
Quality of life will be measured using the EuroQol-5Dimensions-5Levels (EQ-5D-5L) questionnaire
Time Frame: 6 months
|
6 months
|
|
Quality of life will be measured using the EuroQol-5Dimensions-5Levels (EQ-5D-5L) questionnaire
Time Frame: 12 months
|
12 months
|
|
The extent of patient satisfaction with the care they receive, will be measured using the Patient Assessment of Chronic Illness Care (PACIC)
Time Frame: 3 months
|
3 months
|
|
The extent of patient satisfaction with the care they receive, will be measured using the Patient Assessment of Chronic Illness Care (PACIC)
Time Frame: 6 months
|
6 months
|
|
The extent of patient satisfaction with the care they receive, will be measured using the Patient Assessment of Chronic Illness Care (PACIC)
Time Frame: 12 months
|
12 months
|
|
Electronic medical records parameters
Time Frame: 12 months
|
Relevant psychosocial care parameters will be extracted from the EMR to monitor changes in care patterns including previous psychosocial episodes, numbers and types of psychosocial diagnoses, use of screening/diagnostic instruments, comorbidity, treatments, medication prescriptions, referrals and health care consumption.
|
12 months
|
Other Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Health care provider satisfaction with the Assessment of Chronic Illness Care (ACIC)
Time Frame: 12 months
|
12 months
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Mark G Spigt, PhD, Research Institute CAPHRI, Department of Family Medicine, Maastricht University
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- NL44597.068.13/ METC 13-3-034
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Mental Disorders
-
Kansas State UniversityAugusta University; Dartmouth College; University of CincinnatiEnrolling by invitationMental Disorders, Severe | Mental Illness PersistentUnited States
-
VA Boston Healthcare SystemUS Department of Veterans AffairsCompletedMental Health DisordersUnited States
-
Virginia Commonwealth UniversityCompletedMental Health DisordersUnited States
-
Johns Hopkins UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedMental Health DisordersCongo
-
Norwegian University of Science and TechnologySt. Olavs HospitalCompletedMental Health DisordersNorway
-
York UniversityCanadian Institutes of Health Research (CIHR); North York General HospitalCompletedMental Health DisordersCanada
-
University of ManchesterEuropean Research CouncilRecruitingMental Disorders, SevereUnited Kingdom
-
Fundació Institut de Recerca de l'Hospital de la...Active, not recruitingMental Disorders, SevereSpain
-
University of North Carolina, Chapel HillU.S. Department of JusticeCompletedMental Disorders, SevereUnited States
-
Liga Romana pentru Sanatate MintalaPsychiatric Hospital for Chronic Patients Siret, Suceava, RomaniaUnknown
Clinical Trials on SGE-PsyScan
-
Momotaro-Gene Inc.The Pacific Link Consulting CoCompletedLocalized Prostate CancerUnited States
-
Momotaro-Gene Inc.Baylor College of Medicine; Synteract, Inc.Active, not recruitingMalignant Pleural MesotheliomaUnited States